Astragaloside IV: a potential nemesis for gastric cancer
Gastric cancer (GC), a life-threatening malignancy with profound global health impacts, remains a cardinal focus of biomedical research. Recently, astragaloside IV (AS-IV), a bioactive triterpenoid saponin derived from Astragalus mongholicus Bunge, has garnered substantial attention for its multifac...
Saved in:
Main Authors: | Chao Hu, Qiong Li, Song-Nan Gong, Xiao-Jie Zou, Jia-Yue Xu, Hai-Feng Ying, Lan Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1636341/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Review of the Mechanisms of Astragaloside IV and Berberine in Vascular Dysfunction Associated with Obesity and Diabetes
by: Li Y, et al.
Published: (2025-06-01) -
Therapeutic effects and potential mechanisms of astragaloside IV on pulmonary fibrosis: a systematic review and meta-analysis of preclinical studies
by: Shujuan Zhang, et al.
Published: (2025-07-01) -
Astragaloside IV promotes the pyroptosis of airway smooth muscle cells in childhood asthma by suppressing HMGB1/RAGE axis to inactivate NF-κb pathway
by: Huahong Zhang, et al.
Published: (2024-07-01) -
Astragaloside IV Promotes Osteogenic Differentiation of Periodontal Ligament Stem Cells via Activating PI3K/AKT/eNOS/NO Signaling Pathway: In vitro and in vivo Study
by: Song Y, et al.
Published: (2025-07-01) -
Astragaloside II pretreatment alleviates PM2.5-induced lung injury in mice via MAPK/Nrf2/GPX4 axis-mediated suppression of ferroptosis
by: Liyun Liu, et al.
Published: (2025-09-01)